Zamerovimab
Zamerovimab (CTB011) is an anti-rabies humanized IgG1κ monoclonal antibody that binds to the non-overlapping epitopes on the rabies virus (RABV) glycoprotein. Zamerovimab targets residues at and near antigenic site III. Zamerovimab can be used in rabies studies[1].
Product Specifications
CAS Number
2419087-87-7
Product Name Alternative
CTB011
UNSPSC
12352203
Target
RABV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/zamerovimab.html
Solubility
10 mM in DMSO
Smiles
[Zamerovimab]
References & Citations
[1]Tzu-Yuan Chao, et al. SYN023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies. PLoS Negl Trop Dis. 2017 Dec 20;11 (12) :e0006133.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400965-100 1x 100 µL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680031-100 1x 100 µL
Mucin 5AC (MUC5AC) (45M1), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740270-100 1x 100 µL
Fibronectin (HFN7.1), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741135-100 1x 100 µL
P21 / WAF1 (CIP1/823 + DCS-60.2), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC941372-100 1x 100 µL
Ep-CAM / CD326 (Extracellular Domain) (Epithelial Marker) (EGP40/1372), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880970-100 1x 100 µL
GLG1 (Golgi Complex) (GLG1/970), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details